Profile
| Metric | Value |
|---|---|
| Full Name | Viracta Therapeutics, Inc. |
| Ticker | NASDAQ: VIRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | viracta.com |
| Employees | 26 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.01 | |
| Price, 1D Change | - | |
| $389K | ||
| - | ||
| - | ||
| 0.86 | ||
| - | ||
| Revenue, 1Y Change | - | |
| -$1.32 | ||
| EPS, 1Y Change | -1.54% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 57:200 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SNSS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.32 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| - | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.01 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.27 | -$1.32 | -3.94% | |
| - | N/A | - | |
| -$0.39 | N/A | +70.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - | |
| $3.50M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.01 | |
| $0.01 | ||
| SMA 200 vs Price | +44.90% | |
| $0.01 | ||
| SMA 50 vs Price | 0.00% | |
| 0.86 | ||
| $0.00 | ||
| 50.00 | ||
| 0.00% | ||
| 304.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| - | ||
| -$1.32 | ||
| - | ||
| - | ||
| -$50.69M | ||
| - | ||
| -$51.06M | ||
| - | ||
| -$46.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.40 | ||
| 1.43 | ||
| - | ||
| -12.78 | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -0.06 | ||
| -0.11 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $12.87M | ||
| $12.32M | ||
| $56.69M | ||
| $54.96M | ||
| $38.37M | ||
| $38.37M | ||
| $25.56M | ||
| $25.56M | ||
| $2.44M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $50.69M | ||
| $50.69M | ||
| - | ||
| $17.32M | ||
| $492.00K | ||
| $3.70M | ||
| - |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$39.89M | ||
| $15.00M | ||
| $438.00K | ||
| - | ||
| -$40.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Rodman & Renshaw | → | |
| RBC Capital | → | |
| Leerink Partners | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with VIRX
FAQ
What is the ticker symbol for Viracta Therapeutics, Inc.?
The ticker symbol for Viracta Therapeutics, Inc. is NASDAQ:VIRX
Does Viracta Therapeutics, Inc. pay dividends?
No, Viracta Therapeutics, Inc. does not pay dividends
What sector is Viracta Therapeutics, Inc. in?
Viracta Therapeutics, Inc. is in the Healthcare sector
What industry is Viracta Therapeutics, Inc. in?
Viracta Therapeutics, Inc. is in the Biotechnology industry
What country is Viracta Therapeutics, Inc. based in?
Viracta Therapeutics, Inc. is headquartered in United States
When did Viracta Therapeutics, Inc. go public?
Viracta Therapeutics, Inc. initial public offering (IPO) was on September 27, 2005
Is Viracta Therapeutics, Inc. in the S&P 500?
No, Viracta Therapeutics, Inc. is not included in the S&P 500 index
Is Viracta Therapeutics, Inc. in the NASDAQ 100?
No, Viracta Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Viracta Therapeutics, Inc. in the Dow Jones?
No, Viracta Therapeutics, Inc. is not included in the Dow Jones index
When was Viracta Therapeutics, Inc. last earnings report?
Viracta Therapeutics, Inc.'s most recent earnings report was on August 6, 2025
When does Viracta Therapeutics, Inc. report earnings?
The date for Viracta Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- VIRX Official Website www.viracta.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061027/000095017024126385/0000950170-24-126385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061027/000095017024027982/0000950170-24-027982-index.htm
- VIRX Profile on Yahoo Finance finance.yahoo.com/quote/VIRX
- VIRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/virx